Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 1/20 | 0.51 |
| ▸ | GRIA4 | P48058 | 6/20 | 0.45 |
| ▸ | GRIA1 | P42261 | 6/20 | 0.45 |
| ▸ | GRIA3 | P42263 | 6/20 | 0.45 |
| ▸ | GRIA2 | P42262 | 5/20 | 0.45 |
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | NOS1 | P29475 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ALPI | P09923 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | XIAP | P98170 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8824879 | 1.00 | SLC1A3 (0.51) | SLC1A3GRIA4GRIA1GRIA3GRIA2 | |
| SCHEMBL8824882 | 1.00 | SLC1A3 (0.51) | SLC1A3GRIA4GRIA1GRIA3GRIA2 | |
| SCHEMBL28559 | 1.00 | SLC1A3 (0.51) | SLC1A3GRIA4GRIA1GRIA3GRIA2 | |
| SCHEMBL4587261 | 1.00 | SLC1A3 (0.51) | SLC1A3GRIA4GRIA1GRIA3GRIA2 | |
| Hydrochloric Acid SCHEMBL7049998 | 0.98 | SLC1A3 (0.50) | SLC1A3GRIA4GRIA1GRIA3GRIA2 | |
| Homoserine SCHEMBL28894150 | 0.91 | NOS1 (0.45) | SLC1A3GRIA4GRIA1GRIA3GRIA2 | |
| SCHEMBL12610414 | 0.91 | SLC1A3 (0.44) | SLC1A3GRIA4GRIA1GRIA3GRIA2 | |
| SCHEMBL12610410 | 0.91 | SLC1A3 (0.44) | SLC1A3GRIA4GRIA1GRIA3GRIA2 | |
| Sarcosine SCHEMBL16540746 | 0.89 | SLC1A3 (0.43) | SLC1A3GRIA4GRIA1GRIA3GRIA2 | |
| Sarcosine SCHEMBL16540745 | 0.89 | SLC1A3 (0.43) | SLC1A3GRIA4GRIA1GRIA3GRIA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 20040 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122036541-A | Amino acid-based ionizable lipid compound, and preparation method and application thereof | 中国科学院广州生物医药与健康研究院 | 2026-05-15 | — | — | CN | claimed |
| WO-2026100273-A1 | METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, APPARATUS FOR PRODUCING USEFUL SUBSTANCE, AND ALGAE CONTAINING USEFUL SUBSTANCE | ＮＴＴ株式会社 | 2026-05-15 | — | — | WO | claimed |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | claimed |
| EP-4679087-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| US-12517140-B2 | Biomarkers for predicting intensive care unit stay duration for mechanically ventilated covid-19 patients | QATAR UNIVERSITY (QA) | 2026-01-06 | — | — | US | claimed |
| US-12428447-B2 | Peptide-based non-proteinaceous cargo delivery | FELDAN BIO INC. (CA) | 2025-09-30 | — | — | US | claimed |
| WO-2025133394-A1 | METABOLIC FINGERPRINTING OF SALIVA SAMPLES USING NMR | MAVEN HEALTH GMBH (CH) | 2025-06-26 | — | — | WO | claimed |
| WO-2025104600-A1 | INSULIN ANALOGS FOR THE TREATMENT OF HUMAN METABOLIC DISORDER AND DISEASE | Ambio, Inc. (US) | 2025-05-22 | — | — | WO | claimed |
| US-20250154220-A1 | INSULIN ANALOGS FOR THE TREATMENT OF HUMAN METABOLIC DISORDER AND DISEASE | Ambio, Inc. | 2025-05-15 | — | — | US | claimed |
| WO-1991004040-A1 | TREATMENT OF COLON CANCER | BIOMEASURE, INC. (US) | 1991-04-04 | — | — | WO | claimed |
| WO-1991002746-A1 | THERAPEUTIC PEPTIDES | BIOMEASURE, INC. (US) | 1991-03-07 | — | — | WO | claimed |
| WO-1990006102-A1 | COMPOUND AND METHOD FOR THE RETARDATION OF COLLAGEN CROSS-LINKING | PEPTIDE TECHNOLOGY LIMITED (AU) | 1990-06-14 | — | — | WO | claimed |
| WO-1990003980-A1 | THERAPEUTIC PEPTIDES | ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 1990-04-19 | — | — | WO | claimed |
| EP-0291626-A2 | Process for the preparation of optically-active cyanomethyl esters | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-11-23 | — | — | EP | claimed |
| US-4570017-A | Preparation of optically-active (mixed) anhydrides and acids | SHELL OIL COMPANY (US) | 1986-02-11 | — | — | US | claimed |
| US-4560515-A | NON-SYMMETRICAL KETENE REACTED WITH A-HYDROXYNITRILE; TERTUARY AMINE CATALYST | SHELL OIL COMPANY (US) | 1985-12-24 | — | — | US | claimed |
| US-4529810-A | Preparation of optically-active alpha-substituted carboxylic esters and acids | SHELL OIL COMPANY (US) | 1985-07-16 | — | — | US | claimed |
| EP-0116914-A1 | Preparation of optically-active alpha-substituted carboxylic esters and acids | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-08-29 | — | — | EP | claimed |
| EP-0109681-A2 | process for the preparation of optically-active cyanomethyl esters | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-05-30 | — | — | EP | claimed |